Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 434, pseudogene (RNU6-434P) is classified as a small nuclear RNA pseudogene, meaning it is a non-protein-coding genomic DNA sequence similar to the functional U6 small nuclear RNA (snRNA) gene but is generally considered non-functional and not expressed as an active snRNA[5][2]. Functional U6 snRNA is a key component of the spliceosome, the molecular machinery responsible for splicing pre-mRNA in eukaryotic cells, and is highly conserved due to its essential role in RNA processing[1][3]. However, RNU6-434P, as a pseudogene, does not produce an active RNA molecule and does not contribute directly to cellular processes, therapeutic targeting, or disease mechanisms. Pseudogenes such as RNU6-434P are common for U6 due to gene duplication and retrotransposition events but are not known drug targets or biomarkers[5][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 434, pseudogene (RNU6-434P).